Kelly Bolton is an Oncology physician affiliated with Washington University in St. Louis. OpenAlex indexes 314 publications with 7,043 citations (h-index 36); ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1 Barnes Jewish Hospital Plz
Div Im Bone Marrow Transplant
Saint Louis, MO 631101003
Telephone
314-454-8304Provider last certified this registry record 21 Oct 2021.
Clinical trials
- BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer
Sponsor: Washington University School of Medicine
- Ivosidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH1
Sponsor: Washington University School of Medicine
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- SERVIER PHARMACEUTICALS LLCProgram year20251 payment
- Aveo Pharmaceuticals, Inc.Program year20251 payment
- Regeneron Healthcare Solutions, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
2 NIH research awards on record, funded 2020–2026 per NIH RePORTER. The latest:
- The impact of inherited and modifiable risk factors on clonal hematopoiesis and age-related disease
Washington University
FY2026$3,158,066R01AG088690 - The impact of inherited and modifiable risk factors on clonal hematopoiesis and age-related disease
Washington University
FY2025$1,424,637R01AG088690 - The impact of inherited and modifiable risk factors on clonal hematopoiesis and age-related disease
Washington University
FY2024$1,276,687R01AG088690
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions
The American Journal of Human Genetics
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Timothy Ley, MD
Washington University in St. Louis
David Gutmann, MD
Washington University in St. Louis
Randall Bateman, MD
Washington University in St. Louis
Victoria Fraser, MD
Washington University in St. Louis
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”